Literature DB >> 31011209

Mechanism for recycling tRNAs on stalled ribosomes.

Matthew C J Yip1, Alexander F A Keszei1, Qing Feng1, Vincent Chu1, Michael J McKenna1, Sichen Shao2.   

Abstract

Aberrantly stalled ribosomes initiate the ribosome-associated quality control (RQC) and mRNA surveillance pathways for the degradation of potentially toxic peptides and faulty mRNAs. During RQC, ANKZF1 (yeast Vms1p) releases ubiquitinated nascent proteins from 60S ribosomal subunits for proteasomal degradation. Here, we use a cell-free system to show that ANKZF1 and Vms1p sever polypeptidyl-tRNAs on RQC complexes by precisely cleaving off the terminal 3'CCA nucleotides universal to all tRNAs. This produces a tRNA fragment that cannot be aminoacylated until its 3'CCA end is restored. The recycling of ANKZF1-cleaved tRNAs is intact in the mammalian cytosol via a two-step process that requires the removal of a 2',3'-cyclic phosphate and TRNT1, the sole CCA-adding enzyme that mediates tRNA biogenesis in eukaryotes. TRNT1 also discriminates between properly folded tRNA substrates and aberrant tRNA substrates, selectively tagging the latter for degradation. Thus, ANKZF1 liberates peptidyl-tRNAs from stalled ribosomes such that the tRNA is checked in an obligate way for integrity before reentry into the translation cycle.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31011209     DOI: 10.1038/s41594-019-0211-4

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  17 in total

Review 1.  Detection and Degradation of Stalled Nascent Chains via Ribosome-Associated Quality Control.

Authors:  Cole S Sitron; Onn Brandman
Journal:  Annu Rev Biochem       Date:  2020-06-20       Impact factor: 23.643

Review 2.  Ribosome-associated quality-control mechanisms from bacteria to humans.

Authors:  Sebastian Filbeck; Federico Cerullo; Stefan Pfeffer; Claudio A P Joazeiro
Journal:  Mol Cell       Date:  2022-04-21       Impact factor: 19.328

3.  Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.

Authors:  Shuangxi Li; Zhihao Wu; Ishaq Tantray; Yu Li; Songjie Chen; Jason Dong; Steven Glynn; Hannes Vogel; Michael Snyder; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

4.  The endoplasmic reticulum P5A-ATPase is a transmembrane helix dislocase.

Authors:  Michael J McKenna; Sue Im Sim; Alban Ordureau; Lianjie Wei; J Wade Harper; Sichen Shao; Eunyong Park
Journal:  Science       Date:  2020-09-25       Impact factor: 47.728

Review 5.  Mechanisms Linking Mitochondrial Dysfunction and Proteostasis Failure.

Authors:  Bingwei Lu; Su Guo
Journal:  Trends Cell Biol       Date:  2020-02-12       Impact factor: 20.808

6.  Convergence of mammalian RQC and C-end rule proteolytic pathways via alanine tailing.

Authors:  Anna Thrun; Aitor Garzia; Yu Kigoshi-Tansho; Pratik R Patil; Charles S Umbaugh; Teresa Dallinger; Jia Liu; Sylvia Kreger; Annarita Patrizi; Gregory A Cox; Thomas Tuschl; Claudio A P Joazeiro
Journal:  Mol Cell       Date:  2021-04-27       Impact factor: 17.970

Review 7.  Diversity and Similarity of Termination and Ribosome Rescue in Bacterial, Mitochondrial, and Cytoplasmic Translation.

Authors:  Andrei A Korostelev
Journal:  Biochemistry (Mosc)       Date:  2021-09       Impact factor: 2.487

Review 8.  Detecting and Rescuing Stalled Ribosomes.

Authors:  Matthew C J Yip; Sichen Shao
Journal:  Trends Biochem Sci       Date:  2021-05-06       Impact factor: 14.264

9.  CTELS: A Cell-Free System for the Analysis of Translation Termination Rate.

Authors:  Kseniya A Lashkevich; Valeriya I Shlyk; Artem S Kushchenko; Vadim N Gladyshev; Elena Z Alkalaeva; Sergey E Dmitriev
Journal:  Biomolecules       Date:  2020-06-16

10.  Elongational stalling activates mitoribosome-associated quality control.

Authors:  Nirupa Desai; Hanting Yang; Viswanathan Chandrasekaran; Razina Kazi; Michal Minczuk; V Ramakrishnan
Journal:  Science       Date:  2020-11-27       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.